Siga Technologies INC Accumulated Other Comprehensive Income
Siga Technologies INC (SIGA) had Accumulated Other Comprehensive Income of $0 as of 2011-12-31, per its 10-K filed 2012-03-01.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2012-03-01
- 2011-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2011-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2011-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2010-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $4.07K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-03-01 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-08 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-01 |
| 2010-12-31 | $4.07K 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |